| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP | Director | Common Stock | 23.3K | $227K | $9.72 | Jun 11, 2025 | Direct |
| DYNAVAX TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 28.5K | Jun 11, 2025 | Direct | ||
| Histogen Inc. | Director | Stock Option (right to buy) | 6.84K | Jun 20, 2023 | Direct | ||
| Oncternal Therapeutics, Inc. | Director | Stock Options | 2.2K | Jun 20, 2024 | Direct | ||
| Zynerba Pharmaceuticals, Inc. | Director | Common Stock | 0 | $1.33 | Oct 10, 2023 | Direct | |
| Zynerba Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 10, 2023 | Direct |